WE FOCUS ON SOLVING REAL WORLD PROBLEMS WITH EXCITING AND NEW TECHNOLOGIES
Bringing new technologies to light that improve quality, enable breakthroughs and simplify workflows is what we’re all about.
Robert Hart, Ph.D.
As CEO, Robert guides the overall direction of Halo Labs. During his tenure at Halo Labs, Robert has directed product development, overseen corporate and academic partnerships, played a central role in bringing in over $6M of funding and been a successful part of the sales team. Robert and President Bernardo Cordovez were selected for Life Science Startup of the year in 2012 by the Greater Philadelphia Alliance for Capital and Technologies. Robert attained his Biomedical Engineering doctorate from Drexel University under Dr. Moses Noh and Dr. Ryszard Lec and completed his post doc at the University of Pennsylvania under Dr. Haim Bau. Robert was also the Valedictorian for Drexel’s class of 2010. Prior to this he worked in bioautomation for Genome Therapeutics and Eppendorf US (formerly Brinkmann).
Bernardo Cordovez, Ph.D.
Prior to starting the company, Bernardo Cordovez was a Postdoctoral Associate at Cornell University, where he also obtained his M.S and Ph.D. degrees. Dr. Cordovez’ wide range of experience is focused in the areas of microfluidics and nanophotonics and spans applications including biomolecule trapping and detection, drug delivery, bioenergy production, and data storage. In 2012, he was named one of Philadelphia’s top 30 under 30 entrepreneurs. Legend has it that Bernardo Cordovez used a loop, a thumbtack and some chewing gum to devise the first commercial NanoTweezer chip.
VP of Sales
Rick comes to Halo Labs with over 15 years of sales and sales management experience in start-up, emerging growth, and market leading life science tools companies. Prior to joining Halo Labs, Rick held senior positions at Unchained Labs and Phasefocus where he launched and built sales organizations and was a key member of the team that grew ForteBio into the bestselling label-free protein characterization platform on the market. Rick has also held sales positions at Molecular Devices, LabKey Software, and Pacific Biomarkers. Rick holds a BS in Biology from the University of Washington and a MS in Biology from the University of Maine.
Brian DiPaolo, Ph.D.
Brian earned his BS and MS in Biomedical Engineering at Drexel University. He went on to earn his Ph.D. in Bioengineering at the University of Pennsylvania in the field of cellular biomechanics and signalling. He joined the Halo Labs team shortly thereafter. His primary responsibilities have included conceptualization, engineering, design, and analysis of the novel NanoTweezer, NT Surface, and NanoTweezer Raman research instruments. In addition to science and engineering, Brian also loves video games, astronomy, building, writing, and time with the family.
Senior Product Engineer
After receiving his degree in Chemical Engineering from the University of Utah, Colby began his career with IM Flash Technologies as an equipment engineer, After a brief time working with Merck, Colby joined the Halo Labs team and is now the senior research and development engineer. When not in the lab, Colby can be found regaling the team with stories of his adventurous Utah childhood, filled with rolling tractor tires down mountains and throwing chickens in the homes of strangers.
Thomas Castner is a hardware engineer with Halo Labs. Prior to Halo Labs, Thomas worked at Gridless Power and SAP. He earned his Master’s Degree in Mechanical Engineering from Carnegie Mellon and is an Alumni of the University of Pennsylvania’s Management and Technology Program. Thomas played football for the Quakers and enjoys flying model rockets.
Xiangning (Sandy) Li
Technical Marketing & Sales Associate
Sandy earned 2 Master’s Degree (Materials Science & Electrical Engineering) from Upenn and her Bachelor’s Degree of Materials Science from Tsinghua University. Instead of making fancy nanoparticles, she’s now helping researchers better characterize their beloved nanoparticles (Yeah, we can take good care of them!).
Prof. David Erickson
Co-Founder & Chairman
Dr. David Erickson is co-founder and Chairman of Optofluidics, Inc.. In addition to his role at Halo Labs, he is the Sibley College Professor of Mechanical Engineering at Cornell University. Prior to joining Cornell, Dr. Erickson was a postdoctoral scholar at the California Institute of Technology and he received his Ph.D. degree from the University of Toronto. In recent years, Dr. Erickson has received the DARPA-MTO Young Faculty Award, the NSF CAREER Award, and the Department of Energy Early Career Award. In 2011 he was awarded the Presidential Early Career Award for Scientists and Engineers (PECASE) by President Obama. He was recently named a fellow of the Optical Society of America.
Dr. Shahram Hejazi
Dr. Shahram Hejazi is a medical device/life science executive with general management experience in both early-stage ventures and large global companies. As a Venture Partner with BioAdvance, he is responsible for investments in device, diagnostics and imaging field. Previously, Dr. Hejazi was the President of Kodak’s life science division (now called Carestream Molecular Imaging), where he had global responsibility for R&D, manufacturing, operations, sales, marketing and service. Before Kodak, he was the CEO of Zargis Medical Corporation (an early stage medical device company that spun-off from Siemens), where he led the company’s efforts in areas ranging from raising capital and technology development to completion of several clinical trials, FDA approval and product launch. Prior to Zargis, Dr. Hejazi was the Head of the Strategic Business Development group at Siemens, responsible for identifying early-stage growth/investment opportunities and new business development in the medical field.
Dr. Joseph D. Keegan
Dr. Keegan has more than 30 years of experience in life science businesses. As CEO at ForteBio, Inc. he led the Series C financing which raised $25M, established product development and sales strategies that resulted in 2007-11 compounded annual revenue growth of 45%, and exited the company through its sale to Pall Corporation returning $160M to investors. During his 9 year tenure at Molecular Devices Corporation, Dr. Keegan grew the company’s revenues from $30M to $185M through internal growth and acquisitions. In 2007, he oversaw its acquisition by MDS Corporation for $615M. Dr. Keegan joined MDC from Becton Dickinson and Company where he served as President of Worldwide Tissue Culture and Vice President, General Manager of Worldwide Flow Cytometry. Prior to Becton Dickinson, Dr. Keegan was Vice President of the Microscopy and Scientific Instruments Division of Leica, Inc. He currently serves on the Boards of Directors of Advanced Cell Diagnostics, Courtagen Life Sciences, Labcyte Corporation as Chairman, Halo Labs, Response Biomedical Corporation (RBM:Toronto), Seahorse Bioscience Inc., Stereotaxis, Inc. (Nasdaq: STXS), Unchained Labs and Wasatch Microfluidics, Inc., ALDA as past Chairman and the San Francisco Opera. Dr. Keegan holds a B.A. in Chemistry from Boston University and a Ph.D. in Physical Chemistry from Stanford University.